Clinical Pharmakinetics by Haas Jimoh Akanbi PDF free download

Topics: Pharmacotherapeutics, Pharmacokinetics, Pharmacogenomics, Pharmacological effect, Therapeutic index, Therapeutic Range, Steady state, pharmacokinetic studies, Therapeutic drug monitoring testing, Minimum Effective Concentration, Maximum Therapeutic Concentration, Minimum Toxic Concentration, Half Life of a drug, First order kinetics, Zero order kinetics, Michaelis-Menten kinetics, Kinetic homogeneity, Antiepileptics, Antimanics, Antineoplastics, Bronchodilators, Chromatographic techniques, Thin layer chromatography, High performance liquid chromatography, Gas chromatography–mass spectroscopy, Therapeutic Range, Antiarrythmics, Antibiotics, Immunosuppressives

Topics: Drug – receptor binding, GRADED DOSE RESPONSE CURVE, Agonist, antagonist, COMPETITIVE ANTAGONISM, IRREVERSIBLE ANTAGONISM, QUANTAL DOSE RESPONSE CURVE, Desensibilisation, tachyphylaxis, Tachyphylaxis

Topics: Pharmacokinetics, Pharmacodynamics, Life Cycle of a Drug, Slow Absorption, Faster Absorption, Bioavailability, Depot Binding, Degradation, Excretion, Drug Effectiveness, Dose-response curve, Therapeutic Index, Effective dose, Lethal dose, Effective concentration, Drug Efficacy, Drug potency, Drug-drug Interactions, Cumulative Effects, Additive Effects, Synergistic Effects, Antagonistic Effects, Agonism, Antagonism, drug-receptor interaction

Topics: Cell membrane composition, drug transport, Aqueous diffusion, Lipid diffusion, Passive non-ionic diffusion, Lipid solubility, Facilitated diffusion, endocytosis, exocytosis, fluid phase phagocytosis, Filtration, Blood perfusion, P-glycoprotein, Blood flow, Tissue storage, Blood-brain barrier, Blood-testis barrier, Sertoli cell barrier, Placental barrier, Glomerular filtration, Tubular secretion, Tubular reabsorption

Topics: vomitting, nausea, Chemoreceptor trigger zone, Antiemetic Drugs, SEROTONIN ANTAGONISTS, 5-HT3 ANTAGONISTS, D2 RECEPTOR ANTAGONISTS, Prokinetic D2-receptor antagonists, Neuroleptic D2 receptor antagonists, antipsychotic receptor antagonists, NEUROKININ1 RECEPTOR ANTAGONISTS, H1-RECEPTOR ANTAGONISTS, MUSCARINIC RECEPTOR ANTAGONISTS, GLUCOCORTICOIDS, CANNABINOIDS

Topics: THYROID GLAND HORMONES, Calcitonin, Triiodothyronine, Thyroxine, THYROID STIMULATING HORMONE, THYROID HORMONES, HYPERTHYROIDISM, Thyrotoxicosis, hypopthyroidism, myxedema, ENDEMIC GOITER, Grave’s disease, MULTINODULAR GOITER, PHARMACOLOGY HYPERTHYROIDISM, THYROTOXICOSIS, ANTITHYROIDS, THIOMIDES, IODIDES, RADIOACTIVE IODIDE, BETA-BLOCKERS, PHARMACOLOGY HYPOTHYROIDISM, Hypoactivity, LEVOTHYROXINE, MULTI NODULAR GLAND, SUBACUTE THYROIDITIS

Topics: Oral administration, Oral drug formulations, Enteric coating, Rectal administration, Intravenous administration, Subcutaneous administration, Intramuscular administration, INJECTION TECHNIQUES, DRUG ELUTING STENTS, DRUG TRAGETING, DRUG NANOTECHNOLOGY

Topics: PLANT-DRUG DISCOVERY, Drug Discovery Process, Genomics, proteomics, Current therapy, Assay Development, Hit Validation, Lead Compound, Lead Optimisation, Preclinical Evaluation, Preclinical toxicity studies, In vivo tests, Test validity, Multiple Ascending Dose, drug Development

Topics: Pharmacodynamics, Pharmacokinetics, Drug behaviour, Therapeutic advantage, Molecular indices, Potassium sparing diuretics, renal epithelial NA channels, Aldosterone Antagonists, urinary excretion, Estrogens, progestins, Diuretics

Topics: anemia, Microcytic anemia, Normocytic anemia, Macrocytic Anemia, Hemolysis, Hemolytic anemia, IRON Kinetics, red blood cell loss, IRON FORMULATIONS, ACUTE IRON TOXICITY, CHRONIC IRON TOXICITY, CYANOCOBALAMIN, COBALAMIN, vitamin b12, SICKLE CELL ANEMIA, folic acid, HYDROXYUREA, HEMATOPOIETIC GROWTH FACTORS, ERYTHROPOIETIN, MYOLOID GROWTH FACTORS, INTERLEUKIN-11, THROMBOPOIETIN AGONISTS

Topics: Blood volume, Measurement of Blood Volume, Regulation of Blood Volume, Osmoreceptors, Volume receptors, Atrial Natriuretic peptide

Topics: Ethics, communication, Clinical pharmacology, Environmental medicine, global health, poisoning, Palliative medicine, symptom control, Molecular cell biology, human genetics, Pharmacokinetics, Pharmacodynamics, Monitoring drug therapy, Adverse drug reactions, Drug interactions, Evidence-based medicine, maternal health, child health, accidents, trauma, conflict, catastrophe, heat injury, cold injury, drowning, air pollution, ionizing radiation, electric shock, lightning strike, smoke, noise, bioterrorism, biowarfare, Cell biology, cell structure, cell, cellular mechanisms, stem cells, human genetic analysis, chromosome, genetic disorders, population genetics, clinical genetics, genetic counselling, genomic medicine, immune system.Innate immune system, Adaptive immune system, Cell migration, HLA molecules, antigen presentation, human major histocompatibility complex, Clinical immunodeficiency, immediate hypersensitivity, allergic disease, Autoimmune disease, Organ rejection, clinical transplantation, Immune-based therapies, Water, electrolytes, Hyponatraemia, Hypernatraemia, Hypokalaemia, Hyperkalaemia, Hypomagnesaemia, Hypermagnesaemia, Hypophosphataemia, Hyperphosphataemia, Acid–base disorders, Water balance, electrolyte balance, Dietary requirements, Protein–energy malnutrition, vitamins, Fat-soluble vitamins, Water-soluble vitamins, Dietary antioxidants, Homocysteine, cardiovascular disease, B vitamins, Nutrition, Ageing, Nutritional support, obesity, Food allergy, food intolerance, alcohol, Clinical practice, Infectious diseases, tropical medicine, Sexually transmitted infections, human immunodeficiency virus, Gastrointestinal disease, Liver disease, Biliary tract disease, pancreatic disease, Haematological disease, Malignant disease, Rheumatic disease, Kidney disease, urinary tract disease, Neurological disease, Psychological medicine, Cardiovascular disease, Respiratory disease, Critical care medicine, Endocrine disease, Lipid disorder, metabolic disorder, Women's health, Skin disease, Ear disease, nose disease, throat disease, eye disease

Topics: CODEINE, NOSCAPINE, PHOLCODEINE, opioid, Dextromethorphan, LOCALLY ACTING ANTITUSSIVES, EXPECTORANTS, GUAIFENESIN, glyceryl guaiacolate, AMMONIUM SALTS, REFLECLY ACTING EXPECTORANTS, MUCOLYTICS, ACETYLCYSTEINE, MYCOMYST, Bromhexine, AMBROXOL, antihistamines, BRONCHODILATORS, cough

Topics: PEPTIDOGLYCAN, Periplasm, BACITRACIN, MOA BACITRACIN, FOSFOMYCIN, MOA FOSFOMYCIN, CYCLOSERINE, MOA CYCLOSERINE, VANCOMYCIN, TEICOPLANIN, DAPTOMYCIN, POLYMIXIN

Topics: ATHEROGENESIS, Endothelial dysfunction, Smooth muscle cell dysfunction, Architectural disruption, LIPOPROTEIN PARTICLES, Primary chylomicronemia, Primary hypertriglyceridemias, Familial hypertriglyceridemia, Familial combined hyperlipoproteinemia, familial dysbetalipoproteinemia, Primary hypercholesterolemias, Familial hypercholesterolemia, Familial ligand-defective Apolipoprotein B, Familial combined hyperlipoproteinemia, hyperlipoproteinemia, Hypercholesterolemias, Hypertriglyceridemias, REDUCTASE INHIBITORS, STATINS, FIBRATES, Fibric acid derivatives, BILE ACID-BINDING RESINS, NICOTINIC ACID, NIACIN, INTESTINAL STEROL ABSORPTION, EZETIMIBE, COMBINATION THERAPY

Topics: SODIUM STIBOGLUCONATE, MEGLUMINE ANTIMONATE, PENTAMIDINE, AMPHOTERICIN, LIPOSOME, MILTEFOSINE, PAROMOMYCIN, Leishmania

Topics: renin angiotensinaldosterone system, Non-renin pathways, ANGIOTENSIN-CONVERTING ENZYME, renin, PRORENIN, CYCLYC ANGIOTENSIN

Topics: BIPOLAR DISORDER’S CRITERIA, Hypomania, mania, Depression, psychosis, Anticonvulsants, Mood stabilizers, Antipsychotics, Combination therapy, VALPROATE, CARBAMAZEPINE, Acetylcholinesterase inhibitors, Electroconvulsive therapy

Topics: arsenic, lead, mercury, Enterohepatic Circulation, Lead toxicity, Plumbism, mercury toxicity, Arsenic Toxicity, Chelating Agents, Ca-EDTA, DIMERCAPROL, broncho-alveolar lavage, SUCCIMER, PENICILLAMINE, DEFEROXAMINE, DEFERASIROX, PRUSSIAN BLUE

Topics: Hemoglobin Abnormalities, Hemoglobin variants